APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pertussis Vaccine

Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.

Selected research

Market Analysis & Forecast

Global Pertussis Vaccine Market Analysis and Forecast 2026-2032

Report ID 17402400029 January 2026192 pages

Choose your research edition.

Industry ResearchPertussis Vaccine Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Pertussis Vaccine Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Pertussis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pertussis Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Pertussis Vaccine Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.

Global pertussis vaccine key players include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology etc. Global top 2 manufacturers hold a share about 90%. Europe is the largest market, with a share over 30%, followed by North America.

This report presents an overview of global market for Pertussis Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Pertussis Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Pertussis Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pertussis Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pertussis Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pertussis Vaccine sales, projected growth trends, production technology, application and end-user industry.

Pertussis Vaccine Segment by Company

Sanofi Pasteur

GSK

Mitsubishi Tanabe Pharma

Wuhan Institute of Biological Products

Walvax Biotechnology

Minhai Biotechnology

KM Biologics

Chengdu Institute of Biological Products

Pertussis Vaccine Segment by Type

Whole-cell Vaccines

Acellular Vaccines

Pertussis Vaccine Segment by Application

12 Months Below

12 Months Above

Pertussis Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pertussis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pertussis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pertussis Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pertussis Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pertussis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pertussis Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pertussis Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Whole-cell Vaccines Major Manufacturers Table 3. Acellular Vaccines Major Manufacturers Table 4. Global Pertussis Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. 12 Months Below Major Manufacturers Table 6. 12 Months Above Major Manufacturers Table 7. Pertussis Vaccine Industry Trends Table 8. Pertussis Vaccine Industry Drivers Table 9. Pertussis Vaccine Industry Opportunities and Challenges Table 10. Pertussis Vaccine Industry Restraints Table 11. Global Pertussis Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Pertussis Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Pertussis Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Pertussis Vaccine Revenue Market Share by Region (2021-2026) Table 15. Global Pertussis Vaccine Revenue Market Share by Region (2027-2032) Table 16. Global Pertussis Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Doses) Table 17. Global Pertussis Vaccine Sales by Region (2021-2026) & (M Doses) Table 18. Global Pertussis Vaccine Sales by Region (2027-2032) & (M Doses) Table 19. Global Pertussis Vaccine Sales Market Share by Region (2021-2026) Table 20. Global Pertussis Vaccine Sales Market Share by Region (2027-2032) Table 21. Global Pertussis Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Pertussis Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Pertussis Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Pertussis Vaccine Sales Market Share by Manufacturers (2021-2026) Table 25. Global Pertussis Vaccine Sales Price (USD/Doses) of Manufacturers (2021-2026) Table 26. Global Pertussis Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Pertussis Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Pertussis Vaccine Manufacturers, Product Type & Application Table 29. Global Pertussis Vaccine Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Pertussis Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Pertussis Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Pertussis Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Pertussis Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Pertussis Vaccine Revenue Market Share by Type (2021-2026) Table 36. Global Pertussis Vaccine Revenue Market Share by Type (2027-2032) Table 37. Global Pertussis Vaccine Sales by Type 2021 VS 2025 VS 2032 (M Doses) Table 38. Global Pertussis Vaccine Sales by Type (2021-2026) & (M Doses) Table 39. Global Pertussis Vaccine Sales by Type (2027-2032) & (M Doses) Table 40. Global Pertussis Vaccine Sales Market Share by Type (2021-2026) Table 41. Global Pertussis Vaccine Sales Market Share by Type (2027-2032) Table 42. Global Pertussis Vaccine Price by Type (2021-2026) & (USD/Doses) Table 43. Global Pertussis Vaccine Price by Type (2027-2032) & (USD/Doses) Table 44. Global Pertussis Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Pertussis Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Pertussis Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Pertussis Vaccine Revenue Market Share by Application (2021-2026) Table 48. Global Pertussis Vaccine Revenue Market Share by Application (2027-2032) Table 49. Global Pertussis Vaccine Sales by Application 2021 VS 2025 VS 2032 (M Doses) Table 50. Global Pertussis Vaccine Sales by Application (2021-2026) & (M Doses) Table 51. Global Pertussis Vaccine Sales by Application (2027-2032) & (M Doses) Table 52. Global Pertussis Vaccine Sales Market Share by Application (2021-2026) Table 53. Global Pertussis Vaccine Sales Market Share by Application (2027-2032) Table 54. Global Pertussis Vaccine Price by Application (2021-2026) & (USD/Doses) Table 55. Global Pertussis Vaccine Price by Application (2027-2032) & (USD/Doses) Table 56. Sanofi Pasteur Company Information Table 57. Sanofi Pasteur Business Overview Table 58. Sanofi Pasteur Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 59. Sanofi Pasteur Pertussis Vaccine Product Portfolio Table 60. Sanofi Pasteur Recent Development Table 61. GSK Company Information Table 62. GSK Business Overview Table 63. GSK Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 64. GSK Pertussis Vaccine Product Portfolio Table 65. GSK Recent Development Table 66. Mitsubishi Tanabe Pharma Company Information Table 67. Mitsubishi Tanabe Pharma Business Overview Table 68. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 69. Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio Table 70. Mitsubishi Tanabe Pharma Recent Development Table 71. Wuhan Institute of Biological Products Company Information Table 72. Wuhan Institute of Biological Products Business Overview Table 73. Wuhan Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 74. Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio Table 75. Wuhan Institute of Biological Products Recent Development Table 76. Walvax Biotechnology Company Information Table 77. Walvax Biotechnology Business Overview Table 78. Walvax Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 79. Walvax Biotechnology Pertussis Vaccine Product Portfolio Table 80. Walvax Biotechnology Recent Development Table 81. Minhai Biotechnology Company Information Table 82. Minhai Biotechnology Business Overview Table 83. Minhai Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 84. Minhai Biotechnology Pertussis Vaccine Product Portfolio Table 85. Minhai Biotechnology Recent Development Table 86. KM Biologics Company Information Table 87. KM Biologics Business Overview Table 88. KM Biologics Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 89. KM Biologics Pertussis Vaccine Product Portfolio Table 90. KM Biologics Recent Development Table 91. Chengdu Institute of Biological Products Company Information Table 92. Chengdu Institute of Biological Products Business Overview Table 93. Chengdu Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 94. Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio Table 95. Chengdu Institute of Biological Products Recent Development Table 96. North America Pertussis Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 97. North America Pertussis Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 98. North America Pertussis Vaccine Sales by Type (2021-2026) & (M Doses) Table 99. North America Pertussis Vaccine Sales by Type (2027-2032) & (M Doses) Table 100. North America Pertussis Vaccine Sales Price by Type (2021-2026) & (USD/Doses) Table 101. North America Pertussis Vaccine Sales Price by Type (2027-2032) & (USD/Doses) Table 102. North America Pertussis Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 103. North America Pertussis Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 104. North America Pertussis Vaccine Sales by Application (2021-2026) & (M Doses) Table 105. North America Pertussis Vaccine Sales by Application (2027-2032) & (M Doses) Table 106. North America Pertussis Vaccine Sales Price by Application (2021-2026) & (USD/Doses) Table 107. North America Pertussis Vaccine Sales Price by Application (2027-2032) & (USD/Doses) Table 108. North America Pertussis Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. North America Pertussis Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 110. North America Pertussis Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 111. North America Pertussis Vaccine Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 112. North America Pertussis Vaccine Sales by Country (2021-2026) & (M Doses) Table 113. North America Pertussis Vaccine Sales by Country (2027-2032) & (M Doses) Table 114. North America Pertussis Vaccine Sales Price by Country (2021-2026) & (USD/Doses) Table 115. North America Pertussis Vaccine Sales Price by Country (2027-2032) & (USD/Doses) Table 116. United States Pertussis Vaccine Revenue (2021-2032) & (US$ Million) Table 117. Canada Pertussis Vaccine Revenue (2021-2032) & (US$ Million) Table 118. Mexico Pertussis Vaccine Revenue (2021-2032) & (US$ Million) Table 119. Europe Pertussis Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 120. Europe Pertussis Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 121. Europe Pertussis Vaccine Sales by Type (2021-2026) & (M Doses) Table 122. Europe Pertussis Vaccine Sales by Type (2027-2032) & (M Doses) Table 123. Europe Pertussis Vaccine Sales Price by Type (2021-2026) & (USD/Doses) Table 124. Europe Pertussis Vaccine Sales Price by Type (2027-2032) & (USD/Doses) Table 125. Europe Pertussis Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 126. Europe Pertussis Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 127. Europe Pertussis Vaccine Sales by Application (2021-2026) & (M Doses) Table 128. Europe Pertussis Vaccine Sales by Application (2027-2032) & (M Doses) Table 129. Europe Pertussis Vaccine Sales Price by Application (2021-2026) & (USD/Doses) Table 130. Europe Pertussis Vaccine Sales Price by Application (2027-2032) & (USD/Doses) Table 131. Europe Pertussis Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. Europe Pertussis Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 133. Europe Pertussis Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 134. Europe Pertussis Vaccine Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 135. Europe Pertussis Vaccine Sales by Country (2021-2026) & (M Doses) Table 136. Europe Pertussis Vaccine Sales by Country (2027-2032) & (M Doses) Table 137. Europe Pertussis Vaccine Sales Price by Country (2021-2026) & (USD/Doses) Table 138. Europe Pertussis Vaccine Sales Price by Country (2027-2032) & (USD/Doses) Table 139. Germany Pertussis Vaccine Revenue (2021-2032) & (US$ Million) Table 140. France Pertussis Vaccine Revenue (2021-2032) & (US$ Million) Table 141. U.K. Pertussis Vaccine Revenue (2021-2032) & (US$ Million) Table 142. Italy Pertussis Vaccine Revenue (2021-2032) & (US$ Million) Table 143. Russia Pertussis Vaccine Revenue (2021-2032) & (US$ Million) Table 144. Spain Pertussis Vaccine Revenue (2021-2032) & (US$ Million) Table 145. Netherlands Pertussis Vaccine Revenue (2021-2032) & (US$ Million) Table 146. Switzerland Pertussis Vaccine Revenue (2021-2032) & (US$ Million) Table 147. Sweden Pertussis Vaccine Revenue (2021-2032) & (US$ Million) Table 148. Poland Pertussis Vaccine Revenue (2021-2032) & (US$ Million) Table 149. China Pertussis Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 150. China Pertussis Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 151. China Pertussis Vaccine Sales by Type (2021-2026) & (M Doses) Table 152. China Pertussis Vaccine Sales by Type (2027-2032) & (M Doses) Table 153. China Pertussis Vaccine Sales Price by Type (2021-2026) & (USD/Doses) Table 154. China Pertussis Vaccine Sales Price by Type (2027-2032) & (USD/Doses) Table 155. China Pertussis Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 156. China Pertussis Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 157. China Pertussis Vaccine Sales by Application (2021-2026) & (M Doses) Table 158. China Pertussis Vaccine Sales by Application (2027-2032) & (M Doses) Table 159. China Pertussis Vaccine Sales Price by Application (2021-2026) & (USD/Doses) Table 160. China Pertussis Vaccine Sales Price by Application (2027-2032) & (USD/Doses) Table 161. Asia Pertussis Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 162. Asia Pertussis Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 163. Asia Pertussis Vaccine Sales by Type (2021-2026) & (M Doses) Table 164. Asia Pertussis Vaccine Sales by Type (2027-2032) & (M Doses) Table 165. Asia Pertussis Vaccine Sales Price by Type (2021-2026) & (USD/Doses) Table 166. Asia Pertussis Vaccine Sales Price by Type (2027-2032) & (USD/Doses) Table 167. Asia Pertussis Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 168. Asia Pertussis Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 169. Asia Pertussis Vaccine Sales by Application (2021-2026) & (M Doses) Table 170. Asia Pertussis Vaccine Sales by Application (2027-2032) & (M Doses) Table 171. Asia Pertussis Vaccine Sales Price by Application (2021-2026) & (USD/Doses) Table 172. Asia Pertussis Vaccine Sales Price by Application (2027-2032) & (USD/Doses) Table 173. Asia Pertussis Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. Asia Pertussis Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 175. Asia Pertussis Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 176. Asia Pertussis Vaccine Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 177. Asia Pertussis Vaccine Sales by Country (2021-2026) & (M Doses) Table 178. Asia Pertussis Vaccine Sales by Country (2027-2032) & (M Doses) Table 179. Asia Pertussis Vaccine Sales Price by Country (2021-2026) & (USD/Doses) Table 180. Asia Pertussis Vaccine Sales Price by Country (2027-2032) & (USD/Doses) Table 181. Japan Pertussis Vaccine Revenue (2021-2032) & (US$ Million) Table 182. South Korea Pertussis Vaccine Revenue (2021-2032) & (US$ Million) Table 183. India Pertussis Vaccine Revenue (2021-2032) & (US$ Million) Table 184. Australia Pertussis Vaccine Revenue (2021-2032) & (US$ Million) Table 185. Taiwan Pertussis Vaccine Revenue (2021-2032) & (US$ Million) Table 186. Southeast Asia Pertussis Vaccine Revenue (2021-2032) & (US$ Million) Table 187. SAMEA Pertussis Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 188. SAMEA Pertussis Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 189. SAMEA Pertussis Vaccine Sales by Type (2021-2026) & (M Doses) Table 190. SAMEA Pertussis Vaccine Sales by Type (2027-2032) & (M Doses) Table 191. SAMEA Pertussis Vaccine Sales Price by Type (2021-2026) & (USD/Doses) Table 192. SAMEA Pertussis Vaccine Sales Price by Type (2027-2032) & (USD/Doses) Table 193. SAMEA Pertussis Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 194. SAMEA Pertussis Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 195. SAMEA Pertussis Vaccine Sales by Application (2021-2026) & (M Doses) Table 196. SAMEA Pertussis Vaccine Sales by Application (2027-2032) & (M Doses) Table 197. SAMEA Pertussis Vaccine Sales Price by Application (2021-2026) & (USD/Doses) Table 198. SAMEA Pertussis Vaccine Sales Price by Application (2027-2032) & (USD/Doses) Table 199. SAMEA Pertussis Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 200. SAMEA Pertussis Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 201. SAMEA Pertussis Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 202. SAMEA Pertussis Vaccine Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 203. SAMEA Pertussis Vaccine Sales by Country (2021-2026) & (M Doses) Table 204. SAMEA Pertussis Vaccine Sales by Country (2027-2032) & (M Doses) Table 205. SAMEA Pertussis Vaccine Sales Price by Country (2021-2026) & (USD/Doses) Table 206. SAMEA Pertussis Vaccine Sales Price by Country (2027-2032) & (USD/Doses) Table 207. Brazil Pertussis Vaccine Revenue (2021-2032) & (US$ Million) Table 208. Argentina Pertussis Vaccine Revenue (2021-2032) & (US$ Million) Table 209. Chile Pertussis Vaccine Revenue (2021-2032) & (US$ Million) Table 210. Colombia Pertussis Vaccine Revenue (2021-2032) & (US$ Million) Table 211. Peru Pertussis Vaccine Revenue (2021-2032) & (US$ Million) Table 212. Saudi Arabia Pertussis Vaccine Revenue (2021-2032) & (US$ Million) Table 213. Israel Pertussis Vaccine Revenue (2021-2032) & (US$ Million) Table 214. UAE Pertussis Vaccine Revenue (2021-2032) & (US$ Million) Table 215. Turkey Pertussis Vaccine Revenue (2021-2032) & (US$ Million) Table 216. Iran Pertussis Vaccine Revenue (2021-2032) & (US$ Million) Table 217. Egypt Pertussis Vaccine Revenue (2021-2032) & (US$ Million) Table 218. Key Raw Materials Table 219. Raw Materials Key Suppliers Table 220. Pertussis Vaccine Distributors List Table 221. Pertussis Vaccine Customers List Table 222. Research Programs/Design for This Report Table 223. Authors List of This Report Table 224. Secondary Sources Table 225. Primary Sources List of Figures Figure 1. Pertussis Vaccine Image Figure 2. Global Pertussis Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pertussis Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Whole-cell Vaccines Image Figure 5. Acellular Vaccines Image Figure 6. Global Pertussis Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Pertussis Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. 12 Months Below Image Figure 9. 12 Months Above Image Figure 10. Global Pertussis Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Pertussis Vaccine Revenue (2021-2032) & (US$ Million) Figure 12. Global Pertussis Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Pertussis Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Pertussis Vaccine Revenue Market Share by Region (2021-2032) Figure 15. Global Pertussis Vaccine Sales (2021-2032) & (M Doses) Figure 16. Global Pertussis Vaccine Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Figure 17. Global Pertussis Vaccine Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Pertussis Vaccine Sales YoY (2021-2032) & (M Doses) Figure 19. Europe Pertussis Vaccine Sales YoY (2021-2032) & (M Doses) Figure 20. China Pertussis Vaccine Sales YoY (2021-2032) & (M Doses) Figure 21. Asia (Excluding China) Pertussis Vaccine Sales YoY (2021-2032) & (M Doses) Figure 22. South America, Middle East and Africa Pertussis Vaccine Sales YoY (2021-2032) & (M Doses) Figure 23. Global Pertussis Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Pertussis Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Pertussis Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Pertussis Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Pertussis Vaccine Revenue Market Share by Type (2021-2032) Figure 29. Global Pertussis Vaccine Sales by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 30. Global Pertussis Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Pertussis Vaccine Sales Market Share by Type (2021-2032) Figure 32. Global Pertussis Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Pertussis Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Pertussis Vaccine Revenue Market Share by Application (2021-2032) Figure 35. Global Pertussis Vaccine Sales by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 36. Global Pertussis Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Pertussis Vaccine Sales Market Share by Application (2021-2032) Figure 38. North America Pertussis Vaccine Revenue Share by Type (2021-2032) Figure 39. North America Pertussis Vaccine Sales Share by Type (2021-2032) Figure 40. North America Pertussis Vaccine Revenue Share by Application (2021-2032) Figure 41. North America Pertussis Vaccine Sales Share by Application (2021-2032) Figure 42. North America Pertussis Vaccine Revenue Share by Country (2021-2032) Figure 43. North America Pertussis Vaccine Sales Share by Country (2021-2032) Figure 44. Europe Pertussis Vaccine Revenue Share by Type (2021-2032) Figure 45. Europe Pertussis Vaccine Sales Share by Type (2021-2032) Figure 46. Europe Pertussis Vaccine Revenue Share by Application (2021-2032) Figure 47. Europe Pertussis Vaccine Sales Share by Application (2021-2032) Figure 48. Europe Pertussis Vaccine Revenue Share by Country (2021-2032) Figure 49. Europe Pertussis Vaccine Sales Share by Country (2021-2032) Figure 50. China Pertussis Vaccine Revenue Share by Type (2021-2032) Figure 51. China Pertussis Vaccine Sales Share by Type (2021-2032) Figure 52. China Pertussis Vaccine Revenue Share by Application (2021-2032) Figure 53. China Pertussis Vaccine Sales Share by Application (2021-2032) Figure 54. Asia Pertussis Vaccine Revenue Share by Type (2021-2032) Figure 55. Asia Pertussis Vaccine Sales Share by Type (2021-2032) Figure 56. Asia Pertussis Vaccine Revenue Share by Application (2021-2032) Figure 57. Asia Pertussis Vaccine Sales Share by Application (2021-2032) Figure 58. Asia Pertussis Vaccine Revenue Share by Country (2021-2032) Figure 59. Asia Pertussis Vaccine Sales Share by Country (2021-2032) Figure 60. SAMEA Pertussis Vaccine Revenue Share by Type (2021-2032) Figure 61. SAMEA Pertussis Vaccine Sales Share by Type (2021-2032) Figure 62. SAMEA Pertussis Vaccine Revenue Share by Application (2021-2032) Figure 63. SAMEA Pertussis Vaccine Sales Share by Application (2021-2032) Figure 64. SAMEA Pertussis Vaccine Revenue Share by Country (2021-2032) Figure 65. SAMEA Pertussis Vaccine Sales Share by Country (2021-2032) Figure 66. Pertussis Vaccine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Pertussis Vaccine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Whole-cell Vaccines
  • Acellular Vaccines
Applications
  • 12 Months Below
  • 12 Months Above
Companies covered
  • Sanofi Pasteur
  • GSK
  • Mitsubishi Tanabe Pharma
  • Wuhan Institute of Biological Products
  • Walvax Biotechnology
  • Minhai Biotechnology
  • KM Biologics
  • Chengdu Institute of Biological Products

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pertussis Vaccine Market by Type
  3. 1.2.1 Global Pertussis Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Whole-cell Vaccines
  5. 1.2.3 Acellular Vaccines
  6. 1.3 Pertussis Vaccine Market by Application
  7. 1.3.1 Global Pertussis Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 12 Months Below
  9. 1.3.3 12 Months Above
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Pertussis Vaccine Market Dynamics
  1. 2.1 Pertussis Vaccine Industry Trends
  2. 2.2 Pertussis Vaccine Industry Drivers
  3. 2.3 Pertussis Vaccine Industry Opportunities and Challenges
  4. 2.4 Pertussis Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pertussis Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pertussis Vaccine Revenue by Region
  3. 3.2.1 Global Pertussis Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pertussis Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Pertussis Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Pertussis Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pertussis Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pertussis Vaccine Sales by Region
  9. 3.4.1 Global Pertussis Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pertussis Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Pertussis Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Pertussis Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pertussis Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Pertussis Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pertussis Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pertussis Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pertussis Vaccine Sales by Manufacturers
  6. 4.2.1 Global Pertussis Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pertussis Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pertussis Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pertussis Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pertussis Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pertussis Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pertussis Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Pertussis Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pertussis Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Pertussis Vaccine Tier 1, Tier 2, and Tier 3
5 Pertussis Vaccine Market by Type
  1. 5.1 Global Pertussis Vaccine Revenue by Type
  2. 5.1.1 Global Pertussis Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pertussis Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pertussis Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pertussis Vaccine Sales by Type
  6. 5.2.1 Global Pertussis Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pertussis Vaccine Sales by Type (2021-2032) & (M Doses)
  8. 5.2.3 Global Pertussis Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pertussis Vaccine Price by Type
6 Pertussis Vaccine Market by Application
  1. 6.1 Global Pertussis Vaccine Revenue by Application
  2. 6.1.1 Global Pertussis Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pertussis Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pertussis Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pertussis Vaccine Sales by Application
  6. 6.2.1 Global Pertussis Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pertussis Vaccine Sales by Application (2021-2032) & (M Doses)
  8. 6.2.3 Global Pertussis Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pertussis Vaccine Price by Application
7 Company Profiles
  1. 7.1 Sanofi Pasteur
  2. 7.1.1 Sanofi Pasteur Company Information
  3. 7.1.2 Sanofi Pasteur Business Overview
  4. 7.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Pasteur Pertussis Vaccine Product Portfolio
  6. 7.1.5 Sanofi Pasteur Recent Developments
  7. 7.2 GSK
  8. 7.2.1 GSK Company Information
  9. 7.2.2 GSK Business Overview
  10. 7.2.3 GSK Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 GSK Pertussis Vaccine Product Portfolio
  12. 7.2.5 GSK Recent Developments
  13. 7.3 Mitsubishi Tanabe Pharma
  14. 7.3.1 Mitsubishi Tanabe Pharma Company Information
  15. 7.3.2 Mitsubishi Tanabe Pharma Business Overview
  16. 7.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio
  18. 7.3.5 Mitsubishi Tanabe Pharma Recent Developments
  19. 7.4 Wuhan Institute of Biological Products
  20. 7.4.1 Wuhan Institute of Biological Products Company Information
  21. 7.4.2 Wuhan Institute of Biological Products Business Overview
  22. 7.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio
  24. 7.4.5 Wuhan Institute of Biological Products Recent Developments
  25. 7.5 Walvax Biotechnology
  26. 7.5.1 Walvax Biotechnology Company Information
  27. 7.5.2 Walvax Biotechnology Business Overview
  28. 7.5.3 Walvax Biotechnology Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Walvax Biotechnology Pertussis Vaccine Product Portfolio
  30. 7.5.5 Walvax Biotechnology Recent Developments
  31. 7.6 Minhai Biotechnology
  32. 7.6.1 Minhai Biotechnology Company Information
  33. 7.6.2 Minhai Biotechnology Business Overview
  34. 7.6.3 Minhai Biotechnology Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Minhai Biotechnology Pertussis Vaccine Product Portfolio
  36. 7.6.5 Minhai Biotechnology Recent Developments
  37. 7.7 KM Biologics
  38. 7.7.1 KM Biologics Company Information
  39. 7.7.2 KM Biologics Business Overview
  40. 7.7.3 KM Biologics Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 KM Biologics Pertussis Vaccine Product Portfolio
  42. 7.7.5 KM Biologics Recent Developments
  43. 7.8 Chengdu Institute of Biological Products
  44. 7.8.1 Chengdu Institute of Biological Products Company Information
  45. 7.8.2 Chengdu Institute of Biological Products Business Overview
  46. 7.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio
  48. 7.8.5 Chengdu Institute of Biological Products Recent Developments
8 North America
  1. 8.1 North America Pertussis Vaccine Market Size by Type
  2. 8.1.1 North America Pertussis Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Pertussis Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Pertussis Vaccine Price by Type (2021-2032)
  5. 8.2 North America Pertussis Vaccine Market Size by Application
  6. 8.2.1 North America Pertussis Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Pertussis Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Pertussis Vaccine Price by Application (2021-2032)
  9. 8.3 North America Pertussis Vaccine Market Size by Country
  10. 8.3.1 North America Pertussis Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pertussis Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pertussis Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Pertussis Vaccine Market Size by Type
  2. 9.1.1 Europe Pertussis Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pertussis Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Pertussis Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Pertussis Vaccine Market Size by Application
  6. 9.2.1 Europe Pertussis Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pertussis Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Pertussis Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Pertussis Vaccine Market Size by Country
  10. 9.3.1 Europe Pertussis Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pertussis Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pertussis Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Pertussis Vaccine Market Size by Type
  2. 10.1.1 China Pertussis Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Pertussis Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Pertussis Vaccine Price by Type (2021-2032)
  5. 10.2 China Pertussis Vaccine Market Size by Application
  6. 10.2.1 China Pertussis Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Pertussis Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Pertussis Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pertussis Vaccine Market Size by Type
  2. 11.1.1 Asia Pertussis Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pertussis Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Pertussis Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Pertussis Vaccine Market Size by Application
  6. 11.2.1 Asia Pertussis Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pertussis Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Pertussis Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Pertussis Vaccine Market Size by Country
  10. 11.3.1 Asia Pertussis Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pertussis Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pertussis Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pertussis Vaccine Market Size by Type
  2. 12.1.1 SAMEA Pertussis Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pertussis Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pertussis Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Pertussis Vaccine Market Size by Application
  6. 12.2.1 SAMEA Pertussis Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pertussis Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pertussis Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Pertussis Vaccine Market Size by Country
  10. 12.3.1 SAMEA Pertussis Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pertussis Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pertussis Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pertussis Vaccine Value Chain Analysis
  2. 13.1.1 Pertussis Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pertussis Vaccine Production Mode & Process
  6. 13.2 Pertussis Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pertussis Vaccine Distributors
  9. 13.2.3 Pertussis Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst